The article below may contain offensive and/or incorrect content.
Glioma patients whose tumors were hypermutated showed no significant benefit when treated with checkpoint blockers.Article Correctness Is Author's Responsibility: How ‘hypermutated’ malignant brain tumors escape chemotherapy and immunotherapy
Glioma patients whose tumors were hypermutated showed no significant benefit when treated with checkpoint blockers.
